Jazz Pharmaceuticals Hldrs Elect Former Gilead Exec Laura Hamill to Board >JAZZ
Express News | Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting
Barclays Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $200
Barclays Sticks to Their Buy Rating for Jazz Pharmaceuticals (JAZZ)
Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
Jazz Pharmaceuticals Reprices $2.7 Billion Outstanding Balance of Term Loan Facility
Express News | Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes Due 2026
BofA Securities Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $172
Buy Rating Upheld for Jazz Pharmaceuticals Amidst Potential for Growth and Strategic Revaluation
Express News | Jazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024
Jazz Pharmaceuticals' (NASDAQ:JAZZ) Earnings Trajectory Could Turn Positive as the Stock Climbs 5.5% This Past Week
How Is The Market Feeling About Jazz Pharmaceuticals?
Morgan Stanley Maintains Jazz Pharmaceuticals(JAZZ.US) With Hold Rating, Cuts Target Price to $150
Jazz Pharmaceuticals (JAZZ) Receives a Hold From Morgan Stanley
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
Is The Options Market Predicting A Spike In JAZZ Pharmaceuticals (JAZZ) Stock?
RBC Trims Price Target on Jazz Pharmaceuticals to $175 From $176, Keeps Outperform Rating
Express News | Jazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer
Express News | Jazz Pharmaceuticals PLC : RBC Cuts Target Price to $175 From $176
Assessing Jazz Pharmaceuticals: Insights From 7 Financial Analysts
No Data